The large molecule bioanalytical technologies market has seen considerable growth due to a variety of factors.
• The large molecule bioanalytical technologies market has seen rapid growth, with a forecasted increase from $10.19 billion in 2024 to $11.7 billion in 2025, growing at a CAGR of 14.9%.
This growth is attributed to increased investment in biotechnology research, the growth of proteomics research, the expansion of high-throughput screening, the adoption of next-generation sequencing, and increased use of single-cell analysis.
The large molecule bioanalytical technologies market is expected to maintain its strong growth trajectory in upcoming years.
• The large molecule bioanalytical technologies market is expected to grow to $20.12 billion by 2029, with a CAGR of 14.5%.
Growth is driven by the increasing demand for biologics, the prevalence of chronic diseases, and higher investments in life sciences. Trends include the adoption of digital technologies, AI integration, and advancements in point-of-care testing and real-time analysis.
The growing focus on personalized medicine is expected to drive the large molecule bioanalytical technologies market. Personalized medicine tailors treatments to an individual's genetic makeup and other factors, leading to more effective therapies. In February 2024, the FDA approved 16 new personalized medicines for rare diseases in 2023, a significant increase from 2022, underscoring the market's growth.
The large molecule bioanalytical technologies market covered in this report is segmented –
1) By Product And Services: Products, Services
2) By Technology: Chromatography, Mass Spectrometry, Enzyme-Linked Immunosorbent Assay, Electrophoresis, Polymerase Chain Reaction, Western Blot, Flow Cytometry, Spectrometer, Other Technologies
3) By Application: Biologics, Oligonucleotide Derived Drugs And Molecules, Viral Vector, Cell And Gene Therapy, Nanoparticles And Polymers, Disease Diagnosis, Other Applications
Subsegments:
1) By Products - Instruments ( Mass Spectrometers, Chromatography Systems, Immunoassay Analyzers), Reagents And Consumables ( Antibodies, Enzyme-Linked Immunosorbent Assay (Elisa) Kits), Software ( Data Analysis And Visualization Software)
2) By Services - Analytical Testing Services, Contract Research Organization (Cro) Services, Method Development And Validation Services, Stability Testing Services, Consulting And Training Services
Prominent players in the large molecule bioanalytical technologies market are introducing state-of-the-art technologies like Fourier transform infrared spectroscopy to improve the study and characterization of large molecules. Fourier transform infrared spectroscopy is a method used in large-molecule bioanalytical technology to identify the chemical structure of biomolecules. For example, Edinburgh Instruments Ltd., a scientific instrumentation firm based in the UK, unveiled the IR5, a benchtop Fourier transform infrared (FTIR) spectrometer, in April 2022. This top-tier device is engineered for molecular spectroscopy purposes. It boasts high sensitivity and spectrum resolution, the inclusion of a second detector for enhanced sensitivity, and utilizes Fourier transform photoluminescence (FT-PL) for combined absorption and photoluminescence spectroscopy. The IR5 is also equipped with Miracle software, specifically designed for this device, offering a modern, robust, and user-friendly experience.
Major companies operating in the large molecule bioanalytical technologies market are:
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Laboratory Corporation of America Holdings
• Agilent Technologies Inc.
• Charles River Laboratories International Inc.
• Intertek Group plc
• Shimadzu Corporation
• Bio-Rad Laboratories Inc.
• Qiagen N.V.
• HORIBA Ltd.
• SCIEX
• Bio-Techne Corporation
• Hamilton Company
• Promega Corporation
• Verder Group
• Solvias AG
• Analytik Jena AG
• Genedata AG
• Wyatt Technology Corporation
• Nanalysis Corporation
• Avomeen Analytical Services
• Cergentis B.V.
• Halo Labs Inc.
• Hitachi High-Technologies Corporation
• Precision NanoSystems Inc.
North America was the largest region in the large molecule bioanalytical technologies market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the large molecule bioanalytical technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.